Is it LDL particle size or number that correlates with risk for cardiovascular disease?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11883-008-0059-2.pdf
Reference70 articles.
1. Superko HR, Krauss RM: Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994, 90:1056–1069.
2. MAAS Investigators: Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994, 344:633–638.
3. Rosenson RS, Otvos JD, Freedman DS: Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002, 90:89–94.
4. Waters D, Higginson L, Gladstone P, et al.: Effects of cholesterol lowering on the progression of coronary atherosclerosis in women: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation 1995, 92:2404–2410.
5. Jukema JW, Bruschke VG, van Boven AJ, et al., for the REGRESS Study Group: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995, 91:2528–2540.
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Childhood sexual abuse and cholesterol risk: Testing body mass index as a mediator across gender in a national sample of adults;Child Abuse & Neglect;2024-07
2. Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review;BMC Cardiovascular Disorders;2023-11-01
3. Endocan is Related to Increased Cardiovascular Risk in Type 2 Diabetes Mellitus Patients;Metabolic Syndrome and Related Disorders;2023-09-01
4. The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population;Lipids in Health and Disease;2023-07-21
5. Association of LDL-cholesterol subtractions with cardiovascular disorders: A systematic review;2023-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3